Document:

Amendment to Employment Agreement dater May 8, 2012 with Robert Baffi

 Exhibit 10.4 
 AMENDMENT NO. 1 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of May 8, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Robert A. Baffi, Ph.D. (“Employee”). 

 

	1.	This Amendment No. 1 is intended to amend and modify that certain Amended and Restated Employment Agreement by and between the Company and Employee dated
January 1, 2009 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the
Agreement. Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty-five percent (145%) of the Employee’s then current annual base salary which shall be payable in a lump sum within two weeks after separation of employment,
conditioned on Employee executing the Company’s standard form severance and release agreement, and shall be subject to customary withholding and other applicable payroll processes. Employee shall execute the Company’s standard form
severance and release agreement within sixty (60) days after the Employee’s termination. 
  

	3.	This Amendment No. 1 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and
the same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the
date first written above. 
  

							
	BIOMARIN PHARMACEUTICAL INC.	 	EMPLOYEE
				
	By:	 	 /s/ Jean-Jacques Bienaimé
	 	By:	 	 /s/ Robert A. Baffi

	Name:	 	Jean-Jacques Bienaimé	 		 	Robert A. Baffi, Ph.D.
	Its:	 	Chief Executive OfficerAmendment to Employment  Agreement dater May 8, 2012 with G.Eric Davis

 Exhibit 10.5 
 AMENDMENT NO. 1 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of May 8, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and G. Eric Davis (“Employee”). 
  

	1.	This Amendment No. 1 is intended to amend and modify that certain Amended and Restated Employment Agreement by and between the Company and Employee dated
January 1, 2009 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the
Agreement. Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty percent (140%) of the Employee’s then current annual base salary which shall be payable in a lump sum within two weeks after separation of employment, conditioned
on Employee executing the Company’s standard form severance and release agreement, and shall be subject to customary withholding and other applicable payroll processes. Employee shall execute the Company’s standard form severance and
release agreement within sixty (60) days after the Employee’s termination. 
  

	3.	This Amendment No. 1 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and
the same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the
date first written above. 
  

							
	BIOMARIN PHARMACEUTICAL INC.	 	EMPLOYEE
				
	By:	 	 /s/ Jean-Jacques Bienaimé
	 	By:	 	 /s/ G. Eric Davis

	Name:	 	Jean-Jacques Bienaimé	 		 	G. Eric Davis
	Its:	 	Chief Executive OfficerAmendment to Employment Agreement dater May 8, 2012 with Henry fuchs

 Exhibit 10.6 
 AMENDMENT NO. 1 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of May 8, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Henry J. Fuchs (“Employee”). 
  

	1.	This Amendment No. 1 is intended to amend and modify that certain Employment Agreement by and between the Company and Employee dated March 2, 2009 (the
“Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the Agreement. Except as
expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty-five percent (145%) of the Employee’s then current annual base salary which shall be payable in a lump sum within two weeks after separation of employment,
conditioned on Employee executing the Company’s standard form severance and release agreement, and shall be subject to customary withholding and other applicable payroll processes. Employee shall execute the Company’s standard form
severance and release agreement within sixty (60) days after the Employee’s termination. 
  

	3.	This Amendment No. 1 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and
the same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the
date first written above. 
  

							
	BIOMARIN PHARMACEUTICAL INC.	  	EMPLOYEE
				
	By:	 	 /s/ Jean-Jacques Bienaimé
	  	By:	 	 /s/ Henry J. Fuchs

	Name:	 	Jean-Jacques Bienaimé	  		 	Henry J. Fuchs
	Its:	 	Chief Executive OfficerAmendment to Employment Agreement dater May 8, 2012 with Mark Wood

 Exhibit 10.7 
 AMENDMENT NO. 1 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of May 8, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Mark Wood (“Employee”). 
  

	1.	This Amendment No. 1 is intended to amend and modify that certain Amended and Restated Employment Agreement by and between the Company and Employee dated
January 1, 2009 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in the
Agreement. Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred forty percent (140%) of the Employee’s then current annual base salary which shall be payable in a lump sum within two weeks after separation of employment, conditioned
on Employee executing the Company’s standard form severance and release agreement, and shall be subject to customary withholding and other applicable payroll processes. Employee shall execute the Company’s standard form severance and
release agreement within sixty (60) days after the Employee’s termination. 
  

	3.	This Amendment No. 1 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and
the same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the
date first written above. 
  

							
	BIOMARIN PHARMACEUTICAL INC.	  	EMPLOYEE
				
	By:	 	 /s/ Jean-Jacques Bienaimé
	  	By:	 	 /s/ Mark Wood

	Name:	 	Jean-Jacques Bienaimé	  		 	Mark Wood
	Its:	 	Chief Executive OfficerConsent and Fourth Amendment to Credit Agreement

 EXECUTION VERSION 
 EXHIBIT 10.1 
 CONSENT AND FOURTH AMENDMENT TO CREDIT AGREEMENT

 THIS CONSENT AND FOURTH AMENDMENT TO CREDIT AGREEMENT dated as of January 19, 2012 (this “Fourth
Amendment”), among Endeavour International Corporation, a Nevada corporation (“Holdings”), Endeavour Energy UK Limited, a United Kingdom private limited company (the “Borrower”), the Subsidiary Guarantors party hereto, the
Lenders party hereto and Cyan Partners, LP, as administrative agent (in such capacity, the “Administrative Agent”) and collateral agent (in such capacity, the “Collateral Agent”). Capitalized terms used and not otherwise defined
herein shall have the meanings assigned to such terms in the Credit Agreement referred to below. 
 W I T N E S S E T H:

 WHEREAS, Holdings, the Borrower, the Lenders from time to time party thereto and the Administrative Agent are parties to the
Credit Agreement dated as of August 16, 2010, as amended by the First Amendment to Credit Agreement, U.S. Security Agreement and Subsidiaries Guaranty, dated as of February 3, 2011, by the Second Amendment to Credit Agreement dated as of
June 6, 2011 and by the Third Amendment to Credit Agreement, U.S. Security Agreement and Subsidiaries Guaranty dated as of July 15, 2011 (as amended, restated, supplemented and/or otherwise modified from time to time, the “Credit
Agreement”); 
 WHEREAS, the guarantors from time to time party thereto and the Administrative Agent are parties to the
Subsidiaries Guaranty, dated as of August 16, 2010 (as amended, restated, supplemented and/or otherwise modified from time to time, the “Subsidiaries Guaranty”); 

WHEREAS, subject to the terms and conditions of this Fourth Amendment, Holdings, the Borrower, the Administrative Agent, the Subsidiary
Guarantors and the Required Lenders wish to amend the Credit Agreement as herein provided (the “Credit Agreement Amendment”) including to (a) amend Section 8.09 of the Credit Agreement to reduce the minimum Consolidated EBITDAX
required for the Test Periods ending December 31, 2011 and March 31, 2012 and (b) amend Section 8.10(b) of the Credit Agreement to reduce the minimum PDP Coverage Ratio required as of March 31, 2012; 

WHEREAS, Holdings and Citigroup Global Markets Inc. have entered into the Engagement Letter dated December 23, 2011 pursuant to
which it is contemplated that Holdings will issue an aggregate principal amount of up to $500,000,000 of senior unsecured notes, having terms and conditions reasonably satisfactory to the Administrative Agent (the “Debt Securities”, and
the Debt Securities, together with all other documents (including, without limitation, any agreements governing the Escrow Arrangement referenced below) executed and delivered with respect to the Debt Securities, the “Debt Securities
Documents”) in a public offering or in a Rule 144A or other private placement (the “Debt Securities Issuance”); 

 WHEREAS, the proceeds of the Debt Securities Issuance will be contributed by Holdings to the
Borrower and used, in part, by the Borrower to (a) acquire the Alba Interest, the MacCulloch Interest, the Nicol Interest and the other Interests (each as defined in the CP Purchase Agreement referred to below) from ConocoPhillips (U.K.)
Limited, ConocoPhillips Petroleum Limited and ConocoPhillips (U.K.) Lambda Limited (collectively, “CP”) pursuant to a Sale and Purchase Agreement dated December 23, 2011 (the “CP Purchase Agreement”), among the Borrower and
CP (the “CP Acquisition”) and (b) make a payment to the Administrative Agent (for the ratable benefit of the Lenders) (the “Prepayment”) in an amount (the “Prepayment Amount”) equal to the sum of (i) the
outstanding principal amount of all of the Term Loans, all accrued (and theretofor unpaid) interest on the Term Loans and all other Obligations outstanding under the Credit Agreement and the other Credit Documents, in each case, as of the date of
the Prepayment, plus (ii) 3.0% of the aggregate principal amount of the Term Loans outstanding as of the date of Prepayment; 
 WHEREAS, it is contemplated that (i) the proceeds from the Debt Securities Issuance, (ii) cash in an amount equal to all premiums and fees the payment of which are required in connection with
the redemption of the Debt Securities and (iii) cash in an amount equal to the interest that will accrue on the amounts in the foregoing clauses (i) and (ii) during the period of the Escrow Arrangement (as defined below) will be
placed in escrow for the benefit of the holders of the Debt Securities, pursuant to an escrow agreement in form and substance reasonably acceptable to the Administrative Agent, until the consummation of the Borrower’s purchase of the Alba
Interest pursuant to the CP Acquisition and that, in the event the Borrower does not complete its purchase of the Alba Interest prior to June 30, 2012, such proceeds will be required to be used to immediately redeem all of the Debt Securities
(the “Escrow Arrangement”); and 
 WHEREAS, Holdings and the Borrower have requested that the Administrative Agent and
the Lenders consent to, and the Administrative Agent and the Lenders party hereto have agreed, subject to the terms and conditions set forth herein, to consent to (the “Credit Agreement Consent”), among other things, (a) the Debt
Securities Issuance, (b) the Escrow Arrangement, (c) the exclusion of the Debt Securities from the calculation of (i) Consolidated Net Indebtedness for purposes of determining the Total Leverage Ratio and (ii) Consolidated Net
Secured Indebtedness for purposes of determining the Reserve Coverage Ratio and the PDP Coverage Ratio, (d) the waiver of any mandatory prepayment requirement triggered under Section 4.02(c) of the Credit Agreement on the Issue Date (as
defined below), but only so long as the proceeds of the Debt Securities Issuance are held in escrow in accordance with the Escrow Arrangement, (e) the performance by the Subsidiaries of their obligations, including, without limitation, their
compliance with any covenants, under any Debt Securities Documents and (f) the waiver of Holdings’ compliance with the maximum Total Leverage Ratio permitted under Section 8.08 of the Credit Agreement for the Test Period ended
December 31, 2011 and the Test Period ending March 31, 2012; 
 NOW, THEREFORE, in consideration of the premises,
covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

 

	I.	Credit Agreement Amendments. 

  
 2 

 1. Amendment to Section 8.09. Section 8.09 of the Credit Agreement is
hereby amended to reduce the minimum Consolidated EBITDAX required for the Test Period ended December 31, 2011 and the Test Period ending March 31, 2012 to the amounts set forth below: 

 

					
	 December 31, 2011
	  	$	20,000,000	  
	 March 31, 2012
	  	$	20,000,000	  

 2. Amendment to Section 8.10(b). Section 8.10(b) of the Credit Agreement is hereby
amended and restated to read in full as follows: 
 (b) Holdings will not permit the PDP Coverage as of the last day of any
fiscal quarter ending (i) after the Funding Date and on or prior to March 31, 2012, to be less than 0.25:1.00, and (ii) after March 31, 2012, to be less than 0.50:1.00. 

 

	II.	Credit Agreement Consents. 

1. Consent to Debt Securities Issuance, Escrow Arrangement and Subsidiaries’ Performance of Obligations. Notwithstanding
anything to the contrary contained in Sections 8.01, 8.04, 8.12, 8.14(b) or any other provision of the Credit Agreement, the Debt Securities Issuance, the Escrow Arrangement (including any constructive liens of the holders (or for the benefit of
such holders) of the Debt Securities that may arise pursuant to the Escrow Arrangement), the incurrence of Indebtedness and any related guaranties pursuant to the Debt Securities Documents and the performance by the Subsidiaries of their
obligations, including, without limitation, their compliance with any covenants, under the Debt Securities Documents shall be permitted under the Credit Agreement so long as (a) the Debt Securities Documents are in form and substance reasonably
satisfactory to the Administrative Agent, and in any event expressly permit the Prepayment in the Prepayment Amount to occur upon the release of any proceeds of the Debt Securities Issuance from the Escrow Arrangement other than in connection with a
redemption of all of the Debt Securities, (b) the Debt Securities Issuance shall have occurred on or prior to June 30, 2012 (the date of the Debt Securities Issuance, the “Issue Date”), (c) the Net Cash Proceeds from the
Debt Securities Issuance are, at all times while the Escrow Arrangement remains in effect, sufficient to make the Prepayment in the Prepayment Amount and are applied upon the release of any proceeds of the Debt Securities Issuance from the Escrow
Arrangement (other than in connection with a redemption of all of the Debt Securities) to make the Prepayment in an amount equal to the Prepayment Amount, and (d) in the event that the Borrower does not complete its purchase of the Alba
Interest prior to June 30, 2012, the proceeds held in escrow pursuant to the Escrow Arrangement are applied to redeem 100% of the principal amount of the Debt Securities, together with all accrued and unpaid interest thereon, all premium
applicable thereto and any other obligations outstanding pursuant to the Debt Securities Documentation. 
 2 Waiver of
Mandatory Prepayment Requirement. Notwithstanding anything to the contrary contained in Section 4.02(c) or any other provision of the Credit Agreement, the Administrative Agent and the Lenders party hereto waive any requirement that the
Borrower make any mandatory prepayment of the Term Loans from the proceeds of the Debt Securities Issuance except as provided for in Section 1 of Part II of this Fourth Amendment. 

  
 3 

 3. Waiver of Lien on Proceeds from Debt Securities Issuance. Notwithstanding anything
to the contrary contained in any provision of the Credit Agreement and any Security Document, the Collateral Agent and the Lenders party hereto hereby waive and release any security interests granted to them, pursuant to the terms of the Credit
Agreement and any of the Security Documents, in any and all proceeds from the Debt Securities Issuance held in escrow pursuant to the Escrow Arrangement. 
 4. Consent to Exclusion of Debt Securities from Financial Covenant Calculation. Notwithstanding anything to the contrary contained in Sections 8.08, 8.10 or any other provision of the Credit
Agreement, the Administrative Agent and the Lenders hereby consent to the exclusion of the Debt Securities from the calculation of (a) Consolidated Net Indebtedness for purposes of determining Holdings’ compliance with Section 8.08 of
the Credit Agreement and (b) Consolidated Net Secured Indebtedness for purposes of determining Holdings’ compliance with Section 8.10 of the Credit Agreement, in each case for only so long as the proceeds from the Debt Securities
Issuance are held in escrow pursuant to the Escrow Arrangement. 
 5. Limited Waiver of Section 8.08. The
Administrative Agent and the Lenders hereby waive Holdings’ compliance with the maximum Total Leverage Ratio permitted under Section 8.08 of the Credit Agreement for the Test Period ended December 31, 2011 and the Test Period ending
March 31, 2012. 
  

	III.	Miscellaneous Provisions. 

1. In order to induce the Lenders to enter into this Fourth Amendment, each of Holdings and the Borrower hereby represents and warrants
that: 
 (i) all of the representations and warranties contained in the Credit Documents are true and correct in
all material respects both before and immediately after giving effect to the Fourth Amendment Effective Date, with the same effect as though such representations and warranties had been made on and as of the Fourth Amendment Effective Date (it being
understood that any representation or warranty made as of a specific date shall be true and correct in all material respects as of such specific date); and 
 (ii) no Default or Event of Default exists before or immediately after giving effect to the amendments set forth in this Fourth Amendment on the Fourth Amendment Effective Date. 

2. This Fourth Amendment is limited as specified herein and shall not constitute a modification, acceptance or waiver of any other
provision of the Credit Documents, all of which other provisions are hereby ratified and confirmed and are in full force and effect. Each Credit Party party to this Fourth Amendment acknowledges and agrees that all Guaranteed Obligations (as defined
in the Subsidiaries Guaranty after giving effect to this Fourth Amendment) remain secured by the Security Documents and that the Secured Creditors remain entitled to the benefits of the Security Documents. 

3. This Fourth Amendment may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each
of which counterparts when executed and delivered (including by way of facsimile or other electronic transmission) shall be an original, but all of which shall together constitute one and the same instrument. A complete set of counterparts shall be
lodged with the Borrower and the Administrative Agent. 

  
 4 

 4. THIS FOURTH AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE
CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF NEW YORK (WITHOUT REGARD TO CONFLICTS OF LAWS RULES AND PRINCIPLES THEREUNDER OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW). 

5. The Fourth Amendment shall become effective on the date (the “Fourth Amendment Effective Date”) when each of the following
conditions shall have been satisfied: 
 (i) the Credit Parties, the Administrative Agent and the Required
Lenders shall have signed a counterpart hereof (whether the same or different counterparts) and shall have delivered (including by way of facsimile or other electronic transmission) the same to White & Case LLP, 1155 Avenue of the Americas,
New York, NY 10036 Attention: Patrice Antoine (facsimile number: 212-354-8113 / e-mail address: pantoine@whitecase.com); and 
 (ii) the Borrower shall have paid (a) to the Administrative Agent all fees and reasonable and documented out-of-pocket expenses owing to it in connection with this Fourth Amendment and shall have
reimbursed the Administrative Agent for all reasonable and documented out-of pocket legal expenses of White & Case LLP incurred in connection with the Credit Agreement (including, without limitation, in connection with this Fourth
Amendment) and invoiced on or before the date hereof, (b) to the Administrative Agent, for the account of each Lender that delivers a counterpart signature page to this Fourth Amendment at or prior to 12.00 noon, New York City time, on
January 18, 2012, a consent fee (the “Consent Fee”) in an amount equal to 0.50% of the aggregate principal amount of Term Loans of such Lender, which Consent Fee shall be earned, due and payable in immediately available funds on the
Fourth Amendment Effective Date, and, once paid, shall be non-refundable, and (c) any other fees then due and payable in connection with this Fourth Amendment. 
 6. From and after the Fourth Amendment Effective Date, all references in each Credit Document to the “Credit Agreement” shall be deemed to be references to the Credit Agreement as modified
hereby. 
 7. After the execution and delivery to the Administrative Agent of a fully executed copy of this Fourth Amendment by
the parties hereto, this Fourth Amendment may only be changed, modified or varied by written instrument in accordance with the requirements for the modification of Credit Documents pursuant to Section 11.12 of the Credit Agreement. 

8. For the avoidance of doubt, the parties hereto acknowledge and agree that any failure by Holdings or Borrower to comply with the
requirements of Part II of this Fourth Amendment (including, without limitation, clauses (a) through (d) of Section 1 of Part II hereof) shall constitute an immediate Event of Default under Section 9.03 of the Credit Agreement.

 * * * 

  
 5 

 IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this Consent and
Fourth Amendment to Credit Agreement to be duly executed and delivered as of the date first above written. 
  

					
	ENDEAVOUR INTERNATIONAL CORPORATION
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	J. Michael Kirksey
		 	 Title:	 	 Executive Vice President and

Chief Financial Officer

 Signature Page to Consent and Fourth Amendment 

 
					
	ENDEAVOUR ENERGY UK LIMITED
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name: J. Michael Kirksey
		 	 Title: Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	ENDEAVOUR OPERATING CORPORATION, as
	a Subsidiary Guarantor
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	ENDEAVOUR ENERGY NORTH SEA LLC, as a
	Subsidiary Guarantor
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 ENDEAVOUR ENERGY NORTH SEA L.P., as a
 Subsidiary Guarantor

	
	 By: Endeavour Energy North Sea LLC, its general
 partner

		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 ENDEAVOUR ENERGY NEW VENTURES INC., as a

Subsidiary Guarantor

		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	END MANAGEMENT COMPANY, as a
	Subsidiary Guarantor
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	ENDEAVOUR INTERNATIONAL HOLDING
	B.V., as a Subsidiary Guarantor
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	ENDEAVOUR ENERGY NETHERLANDS B.V.,
	as a Subsidiary Guarantor
		
	By:	 	 /s/ J. Michael Kirksey

		 	 Name:	 	
		 	 Title:	 	

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	CYAN PARTNERS, LP, as Administrative Agent,
	Collateral Agent and as a Lender
		
	By:	 	 /s/ Kevin M. Sisson

		 	Name: Kevin Sisson
		 	Title: Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	CYAN PI INVESTMENTS, LP, as a Lender
		
	By:	 	 /s/ Ashok Nayyar

		 	Name: Ashok Nayyar
		 	Title: Manager

  
 Signature
Page to Consent and Fourth Amendment 

 CYRUS OPPORTUNITIES FUND II, L.P., as a Lender 

By: CYRUS CAPITAL PARTNERS, L.P., 

as Investment Manager 
 By:  /s/ David
Milich                                        
             

        Name: David Milich 

        Title: Chief Operating Officer 

  
 Signature
Page to Consent and Fourth Amendment 

 CYRUS EUROPE FUND, L.P., as a Lender 

By: CYRUS CAPITAL PARTNERS, L.P., 

as Investment Manager 
 By:  /s/ David
Milich                                        
                     
         Name: David Milich 
         Title: Chief Operating Officer 

  
 Signature
Page to Consent and Fourth Amendment 

 CRESCENT 1, L.P., as a Lender 

By: CYRUS CAPITAL PARTNERS, L.P., 

as Investment Manager 
 By:  /s/ David
Milich                                        
             

        Name: David Milich 

        Title: Chief Operating Officer 

  
 Signature
Page to Consent and Fourth Amendment 

 CYR FUND, L.P., as a Lender 

By: CYRUS CAPITAL PARTNERS, L.P., 

       as Investment Manager 

By:  /s/ David
Milich                                        
                 

        Name: David Milich 

        Title: Chief Operating Officer 

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 CYRUS SELECT OPPORTUNITIES FUND, L.P., as a Lender

 
 By: CYRUS CAPITAL PARTNERS, L.P., as Investment Manager

		
	By:	 	/s/ David Milich
		 	Name: David Milich
		 	Title:   Chief Operating Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 CYRUS OPPORTUNITIES MASTER FUND II, LTD., as a Lender

 
 By: CYRUS CAPITAL PARTNERS, L.P., as Investment Manager

		
	By:	 	/s/ David Milich
		 	Name: David Milich
		 	Title:   Chief Operating Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 CYRUS EUROPE MASTER FUND, LTD., as a Lender
  

By: CYRUS CAPITAL PARTNERS, L.P., as Investment Manager

		
	By:	 	/s/ David Milich
		 	Name: David Milich
		 	Title:   Chief Operating Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 CYRUS SELECT OPPORTUNITIES MASTER FUND, LTD., as a Lender

 
 By: CYRUS CAPITAL PARTNERS, L.P., as Investment Manager

		
	By:	 	/s/ David Milich
		 	Name: David Milich
		 	Title:   Chief Operating Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	STEELHEAD NAVIGATOR MASTER, L.P., as a Lender
		
	By:	 	STEELHEAD PARTNERS, LLC, its Investment Manager
		
	By:	 	/s/ Grant Hulse
		 	Name:  Grant Hulse
		 	Title:    Director of Finance and Operations

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 THE ROTHSCHILD FOUNDATION EUROPE, as a Lender.

		
	By:	 	/s/ Avar Bennett
		 	Name:  A. Bennett
		 	Title:    Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 DODER TRUST LIMITED

(as Trustee for the Jader Trust No 4), as a Lender

		
	By:	 	/s/ Randall Kress
		 	Name:	 	Randall Kress
		 	Title:	 	Agent/Secretary

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 DODER TRUST LIMITED

(as Trustee for the Bat Hanadiv Foundation No 3), as a Lender

		
	By:	 	/s/ Randall Kress
		 	Name:	 	Randall Kress
		 	Title:	 	Agent/Secretary

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 MTP ENERGY INFRASTRUCTURE FINANCE MASTER FUND, LTD., as a Lender

		
	By:	 	MTP Energy Management LLC, its Investment Manager
		
	By:	 	Magnetar Financial LLC, its Managing Member
		
	By:	 	/s/ Doug Litowitz
		 	Name:	 	Doug Litowitz
		 	Title:	 	Counsel

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 TRIANGLE PEAK PARTNERS PRIVATE EQUITY, LP, as a Lender

		
	By:	 	Triangle Peak Partners Private Equity GP, LLC, its General Partner
		
	By:	 	/s/ Dain Degruff
		 	Name:	 	Dain Degruff
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	 RIVER BIRCH MASTER FUND, LP, as a Lender

		
	By:	 	/s/ Alex Kirk
		 	Name: Alex Kirk
		 	Title:  Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 FARALLON CAPITAL (AM) INVESTORS, L.P., as a Lender

		
	 By:
	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name:	 	Michael G. Linn
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P., as a Lender

		
	 By:
	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name:	 	Michael G. Linn
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P., as a Lender

		
	 By:
	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name:	 	Michael G. Linn
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	 FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P., as a Lender

		
	 By:
	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name:	 	Michael G. Linn
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
					
	FARALLON CAPITAL OFFSHORE INVESTORS II, L.P., as a Lender
		
	By:	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name:	 	Michael G. Linn
		 	Title:	 	Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	FARALLON CAPITAL PARTNERS, L.P., as a Lender
		
	By:	 	FARALLON PARTNERS, L.L.C., its General Partner
		
	By:	 	/s/ Michael G. Linn
		 	Name: Michael G. Linn
		 	Title:   Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	NOONDAY OFFSHORE, INC., as a Lender
		
	By:	 	FARALLON CAPITAL MANAGEMENT, L.L.C., its Agent and Attorney-in-Fact
		
	By:	 	/s/ Michael G. Linn
		 	Name: Michael G. Linn
		 	Title:   Managing Member

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	WHITEBOX ASYMMETRIC PARTNERS, LP, as a Lender
		
	By:	 	WHITEBOX ASYMMETRIC ADVISORS, LLC, its General Partner
		
	By:	 	WHITEBOX ADVISORS, LLC, its Managing Member
		
	By:	 	/s/ Mark Strefling
		 	Name: Mark Strefling
		 	Title:   Chief Legal Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	WHITEBOX MULTI-STRATEGY PARTNERS, LP, as a Lender
		
	By:	 	WHITEBOX MULTI-STRATEGY ADVISORS, LLC, its General Partner
		
	By:	 	WHITEBOX ADVISORS, LLC, its Managing Member
		
	By:	 	/s/ Mark Strefling
		 	Name: Mark Strefling
		 	Title:   Chief Legal Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
		 	 WHITEBOX CREDIT ARBITRAGE PARTNERS,
 LP, as a Lender

		
	By:	 	WHITEBOX CREDIT ARBITRAGE ADVISORS, LLC, its General Partner
		
	By:	 	WHITEBOX ADVISORS, LLC, its Managing Member
		
	By:	 	/s/ Mark Strefling
		 	Name: Mark Strefling
		 	Title:   Chief Legal Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	PANDORA SELECT PARTNERS, LP, as a Lender
		
	By:	 	PANDORA SELECT ADVISORS, LLC, its General Partner
		
	By:	 	WHITEBOX ADVISORS, LLC, its Managing Member
		
	By:	 	/s/ Mark Strefling
		 	Name: Mark Strefling
		 	Title:   Chief Legal Officer

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	
	JGB CAPITAL, LP, as a Lender
		
	By:	 	/s/ Brett Cohen
		 	Name:    Brett Cohen
		 	Title:      Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	
	JGB CAPITAL OFFSHORE LTD, as a Lender
		
	By:	 	/s/ Brett Cohen
		 	Name:    Brett Cohen
		 	Title:      Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	
	JGB PARTNERS LP, as a Lender
		
	By:	 	/s/ Brett Cohen
		 	Name:    Brett Cohen
		 	Title:      Authorized Signatory

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	
	HELIOS CORPORATE LLC, as a Lender
		
	By:	 	/s/ Elliot Greenberg
		 	Name:    Elliot Greenberg
		 	Title:      Vice President

  
 Signature
Page to Consent and Fourth Amendment 

 
			
	
	SAMC LLC, as a Lender
		
	By:	 	/s/ Craig Effron
		 	Name:    Craig Effron
		 	Title:      Managing Member

  
 Signature
Page to Consent and Fourth Amendment

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]